The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|31|3551-3575

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.31, 2014-10, pp. : 3551-3575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1500-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate and Schizophrenia: Pathophysiology and Therapeutics

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 1, 2002-03 ,pp. : 29-44

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 2, 2004-06 ,pp. : 147-154

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of Parkinson's Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 7, 2012-11 ,pp. : 907-920

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Drug Targets

By  

Current Drug Targets, Vol. 8, Iss. 5, 2007-05 ,pp. : 651-681

Bentham Science Publishers

Access to resources Recommend Favorite